Related references
Note: Only part of the references are listed.Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice
Kuo-Chen Wu et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1)
Anna Vlachodimou et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Adenosine and the Cardiovascular System
Allison B. Reiss et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2019)
Structures of human ENT1 in complex with adenosine reuptake inhibitors
Nicholas J. Wright et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Current Progress on Equilibrative Nucleoside Transporter Function and Inhibitor Design
Shahid Rehan et al.
SLAS DISCOVERY (2019)
Inhibition of human equilibrative nucleoside transporters by 4((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-y1)-1,3,5-triazin-2-amine
Philip C. T. Tang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Equilibrative nucleoside transporter 3 depletion in β-cells impairs mitochondrial function and promotes apoptosis: Relationship to pigmented hypertrichotic dermatosis with insulin-dependent diabetes
B. Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models
D. Dias-da-Silva et al.
TOXICOLOGY IN VITRO (2015)
Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2)
Hilaire Playa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury
Tobias Eckle et al.
FASEB JOURNAL (2013)
Development of Dual PLD1/2 and PLD2 Selective Inhibitors from a Common 1,3,8-Triazaspiro[4.5]decane Core: Discovery of ML298 and ML299 That Decrease Invasive Migration in U87-MG Glioblastoma Cells
Matthew C. O'Reilly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis
Jean Quancard et al.
CHEMISTRY & BIOLOGY (2012)
Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition
Pedro Cano-Soldado et al.
MEDICINAL RESEARCH REVIEWS (2012)
Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors
Markus Boehringer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3
Rajgopal Govindarajan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Nucleoside Transporter Proteins
Miriam Molina-Arcas et al.
CURRENT VASCULAR PHARMACOLOGY (2009)
Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors
Amol Gupte et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors
Wenwei Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH
Kay Barnes et al.
CIRCULATION RESEARCH (2006)
Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells
GPH Leung et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes
SA Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H, 3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters
JR Hammond et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The equilibrative nucleoside transporter family, SLC29
SA Baldwin et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Novel halogenated nitrobenzylthioinosine analogs as es nucleoside transporter inhibitors
A Gupte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
A view of the hydrophobic effect
NT Southall et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2002)
Equilibrative nucleoside transporters: Mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins
M Sundaram et al.
BIOCHEMISTRY (2001)
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells - ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine
JL Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity
JR Hammond
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
Midazolam selectively potentiates the A2A- but not A1-receptor-mediated effects of adenosine
CN Seubert et al.
ANESTHESIOLOGY (2000)
Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication
YG Liu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Share Paper
